SCHEMBL28414537

SCHEMBL28414537

O=c1nc(OC(C2=CC=CCC2)C2=COC=CO2)cc2n1CCc1cc(OC(C3=CC=CCC3)C3=COC=CO3)ccc1-2

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 20/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15826519 0.95 GPR84 (0.47) GPR84
SCHEMBL15822296 0.93 GPR84 (0.48) GPR84
SCHEMBL17508788 0.92 GPR84 (0.48) GPR84
SCHEMBL15826037 0.91 GPR84 (0.37) GPR84
SCHEMBL15825896 0.91 GPR84 (0.35) GPR84
SCHEMBL15825884 0.91 GPR84 (0.42) GPR84
SCHEMBL17508785 0.91 GPR84 (0.50) GPR84
SCHEMBL15822691 0.91 GPR84 (0.50) GPR84
SCHEMBL15824547 0.90 GPR84 (0.50) GPR84
SCHEMBL15825863 0.90 GPR84 (0.50) GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111343986-A Compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases 加拉帕戈斯股份有限公司 2020-06-26 CN claimed
CN-111343986-A Compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases 加拉帕戈斯股份有限公司 2020-06-26 CN disclosed